AviaraDx, MGH Cancer Center, Genomic Health, Roche, Entelos, Pfizer, Illumina, Rosetta Genomics, US Genomics, BioMerieux, Proteome Sciences, SAIC/EAI, CombiMatrix, Herceptin, Nexavar | GenomeWeb

AviaraDx, MGH Cancer Center to Co-Develop Dx for Targeted Cancer Drugs

AviaraDx, formerly known as Arcturus Bioscience, and Massachusetts General Hospital Cancer Center plan to identify molecular profiles for multiple types of cancer, and hope to develop diagnostics that could help predict the way patient may responds to certain targeted cancer drugs, the organizations said last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.